3rd Annual Partnerships in Clinical Trials Asia
Partnerships in Clinical Trials Asia sets the stage for accelerated pharmaceutical innovation in Asia.The largest concentration of clinical decision makers specializing in clinical development, operations and outsourcing meet to provide you the opportunity to establish benchmarks, standards and next practices in the development and commercialization of products in a global marketplace. The agenda is filled with in-depth case studies on strategic partnering and effective outsourcing to ensure quality, control costs and accelerate cures to market.
Conducting clinical research in Asia is no longer simply a strategy to improve timelines and cost-savings – it is the only way to maintain a globally competitive pipeline. And, while site and investigator quality and the availability of a naïve patient population in some Asian countries may be unparalleled, Asia based trials present their own unique operational, regulatory and ethical challenges.
For over 20 years, Partnerships in Clinical Trials has been the trusted partner in examining critical issues and decisions around different sourcing models, who to outsource clinical research to, and best practices in successfully managing the many facets of clinical trials. We are delighted to explore these clinical research topics in Shanghai, China this year.
There is no better time than the present to join the thousands who have participated in Partnerships in Clinical Trials globally, to overcome these challenges, hone your partnerships skills and improve clinical operations.
No other event focuses solely on the business of clinical research and outsourcing. Now in its third year, Partnerships Asia continues to attract senior-level executives who know the value of personal interactions required to foster the understanding of the capabilities and opportunities, infrastructure, and the risks and myths about conducting studies in the region. To view the full list of 2011 event highlights, click here.